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Dear editor;
The coronavirus has spread rapidly all over the world and has
become a worldwide crisis. On 11th March, 2020, the World
Health Organization (WHO) described the coronavirus dis-
ease as a global pandemic. Following the mortality due to
COVID-19 infection, many healthcare systems have been af-
fected in many countries. On July 11th, 2020, 12322395 con-
firmed cases of coronavirus were reported, of which 556335
led to death (1) .
Many countries are faced with some challenging issues such
as increasing elderly population and Limitations of young
and fresh resource. On the other hand, there is the possi-
bility that the coronavirus would negatively affect the rate
of reproduction in many countries. The issue of decreased
reproduction during the COVID-19 outbreak is not limited
to developed countries, and soon many countries will face
population problems. In Italy, with a population of 60.7 mil-
lion people, the annual population decreases by 0.2% and life
expectancy is 82.5 years. The rates of reproduction in Italy,
France, and United States of America were 1.35, 1.96, and
1.80 births per woman, respectively (2). Considering the re-
duction of 170000 births in 2018 in Iran, compared with pre-
vious years, and despite the birth rate of 1196000 births, as
well as the population growth rate decline to less than 1% in
2018, it seems that Iran’s population is aging fast (3). During
the six months of March to August 2020, children were born
who were formed before the coronavirus pandemic and were
born in such harsh conditions. Therefore, in the mentioned
six months, no considerable reduction would be seen in the
rate of birth. However, there is a concern that the rate of birth
would considerably reduce with respect to the present con-
∗Corresponding Author: Rayka Sharifian; Men‘s Health & Reproductive
Health Research Center, Shahid Beheshti University of Medical Sciences,
Tehran, Iran. Email: Sharifian.rayka@sbmu.ac.ir, Tel: +989358552104
ditions and even become negative (2). Considering the de-
crease in population rate due to extensive mortality rate of
COVID-19 infection and lack of interest for pregnancy in cou-
ples, more attention should be paid to infertile patients who
would like to have children (2).
Infertility is defined as not being able to naturally conceive a
child after two year of unprotected intercourse. One of the
methods for treating infertility is ART (Assisted Reproductive
Technology) which increases the chance of fertility using up-
to-date technology. Since this technology is highly important
in infertile couples it should also be considered even dur-
ing the COVID-19 pandemic. Each year, 0.3% of children are
born using ART in United States. This is while during the first
three months of 2020, death due to COVID-19 comprised 1%
of total deaths. Based on the evidences, ART can help bal-
ance the population during this pandemic (4). Alviggi and
colleague suggested that all treatment processes including
in vitro fertilization/ intra uterine insemination (IVF/IUI),
embryo-transfer, and infertility research process be post-
pone(2). On 19th March 2020, the European Society for
Human Reproduction and Embryology suggested that preg-
nancy using embryo-transfer techniques should not be used
and infertile individuals should not go to trips for treating
their infertility in order to reduce the burden on the health-
care system during the pandemic (2). On 30th March 2020,
the American Society for Reproductive Medicine suggested
that new infertility treatments as well as embryo transfers
should be postpone and only those who were started treat-
ment cycles before the coronavirus outbreak or patients who
need emergency stimulation and cryopreservation be treated
(5). The Superior Institute of Health (ISS) and the National
Center of Transplants in Italy also recommended that gamete
donation, ovulation stimulation, and IVF be stopped except
in emergency cases such as in patients with cancer or old
age of the mother (5). Moreover, patients should have no
signs or symptoms of COVID-19 infection. In my opinion in
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Iran, due to population growth policies, the treatment pro-
cess of infertile patients should be followed with greater sen-
sitivity, so stopping all treatment processes and ART does not
seem logical. Therefore, we suggest that according to the Ira-
nian Society for Reproductive Medicine and the guidelines
of Iran’s Ministry of Health, patients whose delay in treat-
ment is not advisable for a long time, including women aged
more than 35 years or low ovarian reserve (Anti Mullerian
Hormone equal to or less than 1.7 and Antral Follicle count
between 5-7 or endometriosis stage 2 and 4, which are can-
didates for IVF and their spouse does not have azoospermia.
These patients can be entered into the treatment cycle by
performing all health protocols for patients and Medical sys-
tem personnel’s (6). It is necessary to freeze the fetus after its
formation and delay the transfer until the condition normal-
izes (5). given that the prognosis of patients who need ovula-
tion stimulation or IUI is appropriate, and these people have
adequate time to delay treatment, it is also recommended
to avoid starting these cycles in order to avoid traveling in
and out of the city and reduce contact, as well as the possi-
ble side effects of Human chorionic gonadotropin (hCG) in-
jection and hyperstimulation syndrome and its subsequent
consequences (6). Our recommendation is that patients with
a long history of infertility without children and those who
are older should be given priority treatment. Also, patients
with malignancy should begin treatment processes. In pa-
tients with malignancy, in addition to the above protocols,
the service provider must urgently perform embryo storage
and transfer processes. Also, those who started treatment be-
fore the SARS-COV-2 pandemic need to complete it. How-
ever, health care systems need to provide special facilities for
these groups so that in addition to not imposing additional
burden on the health care system, reduce the risk of COVID-
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